-
“Invisible Illness” could have been transgressive. Instead, it minimizes Long COVID.
The book fails to convey the severity of infection-associated chronic conditions, demands for treatment, or importance of infection prevention. Read more…
Recent articles
Get the latest Long COVID news and commentary
Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
Check out our weekly podcast, Still Here
Spotify
Apple Podcasts
PocketCasts
Amazon Music
iHeartRadio
RSSTrending
Policy & Advocacy
-
Maryland considers Long COVID innovation bill
-
HHS hosts event and announces new initiatives for Lyme disease, but advocates are skeptical about follow-through
-
“Medically neglected” and “structurally erased”: International network appeals for ME advocate Nevra Elis
-
Doctors who refuse to engage with administrative work are abandoning their poorest and sickest patients
-
Leslie Lee III, culture critic and Long COVID advocate, dies at 43
-
The future of Medicaid is “really scary” for people with Long COVID
Science
-
Research updates, February 10
-
Long COVID affects millions of children. The largest pediatric trial so far launches this year.
-
Research updates, February 3
-
Research updates, January 27
-
New RECOVER-TLC trials won’t enroll until summer. Nearly two years after the program’s launch.
-
Research updates, January 20
Covid-19
Health
-
Winter Olympic athletes are rightfully taking COVID-19 precautions
-
Long COVID affects millions of children. The largest pediatric trial so far launches this year.
-
Metrodora promised comprehensive treatment. But within two years, it abruptly closed.
-
The CDC just sidelined these childhood vaccines. Here’s what they prevent.
-
Editor’s note: An update on a recent book excerpt
-
New AI tools are helping some people manage Long COVID
-
We need more at-home clinical trials for Long COVID. Here’s how we designed the largest one yet.
-
Vyvgart brought us back to life, but the Long COVID trial was canceled. We are calling on the NIH and HHS to study the drug.
-
Long COVID inspired me to start an IACC case competition at my business school. Here’s how you can get involved.
-
Patricia Lockwood explores the depths of Long COVID in the new novel “Will There Ever Be Another You”